Webinars and E-Learning
Sharing our expertise
Advancements in Blood Biomarker Research in Traumatic Brain Injury
Presenter: Jeff Snell, Ph.D.
Date: July 15, 2026
Time: 9:00 AM
Duration: 50 Minutes Presentation, 10 Minutes Q&A
WEBINAR SUMMARY
Blood biomarkers have the potential to transform the way clinicians detect, quantify, and manage traumatic brain injury (TBI). A brief history of the development of blood biomarkers for TBI will be presented, as well as an overview of the current biomarkers and related technology with the strongest evidence base to date (current FDA approval). Attendees will learn how emerging biomarker profiles differentiate injury phenotypes, help to predict recovery trajectories, and support decision‑making across acute care, sports and military environments. The current applications in mild TBI will be presented, as well as potential applications of this technology for moderate to severe TBI.
In addition to a review of the rapidly-developing advancements in this field of research, we will discuss limitations, issues of biological variability, implementation challenges, as well as present and potential pathways for clinical translation. The goal of this information is to provide a practical understanding of where blood biomarkers for TBI science stands today; what is currently clinically actionable, and how biomarkers may change the future of diagnostics and recovery planning.
Stay Connected
Complete the form below and you’ll receive updates on the educational opportunities, events, and stories of inspiration.
